Laura Casorzo

1.7k total citations
29 papers, 1.2k citations indexed

About

Laura Casorzo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Laura Casorzo has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Laura Casorzo's work include HER2/EGFR in Cancer Research (5 papers), Cancer Genomics and Diagnostics (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Laura Casorzo is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Cancer Genomics and Diagnostics (5 papers) and Lung Cancer Treatments and Mutations (4 papers). Laura Casorzo collaborates with scholars based in Italy, United States and Belarus. Laura Casorzo's co-authors include Anna Sapino, Mauro Risio, Caterina Marchiò, Enrico Berrino, Laura Annaratone, Ana Marques, Ivana Sarotto, Massimo Aglietta, Paolo M. Comoglio and Silvia Giordano and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Cancer Research.

In The Last Decade

Laura Casorzo

29 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Casorzo Italy 19 665 319 300 260 230 29 1.2k
Marcel Bundi Switzerland 7 602 0.9× 242 0.8× 317 1.1× 212 0.8× 251 1.1× 7 1.2k
Philipp Lohneis Germany 19 643 1.0× 169 0.5× 265 0.9× 206 0.8× 182 0.8× 57 1.1k
Xiaopei Zhu United States 15 354 0.5× 484 1.5× 344 1.1× 107 0.4× 158 0.7× 22 1.1k
Leonardo Faoro United States 16 691 1.0× 344 1.1× 686 2.3× 192 0.7× 248 1.1× 36 1.6k
Herman Bril Netherlands 18 439 0.7× 159 0.5× 312 1.0× 161 0.6× 238 1.0× 56 1.1k
Raija Ristamäki Finland 21 760 1.1× 230 0.7× 535 1.8× 307 1.2× 200 0.9× 52 1.3k
Koh‐ichi Sakata Japan 22 498 0.7× 321 1.0× 303 1.0× 203 0.8× 496 2.2× 85 1.4k
Naoki Kanomata Japan 22 840 1.3× 528 1.7× 549 1.8× 337 1.3× 216 0.9× 104 1.7k
Martin Illemann Denmark 19 608 0.9× 162 0.5× 373 1.2× 478 1.8× 153 0.7× 39 1.2k
Priyanka Shivdasani United States 9 661 1.0× 664 2.1× 412 1.4× 357 1.4× 253 1.1× 11 1.4k

Countries citing papers authored by Laura Casorzo

Since Specialization
Citations

This map shows the geographic impact of Laura Casorzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Casorzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Casorzo more than expected).

Fields of papers citing papers by Laura Casorzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Casorzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Casorzo. The network helps show where Laura Casorzo may publish in the future.

Co-authorship network of co-authors of Laura Casorzo

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Casorzo. A scholar is included among the top collaborators of Laura Casorzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Casorzo. Laura Casorzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berrino, Enrico, Laura Annaratone, Sara E. Bellomo, et al.. (2022). Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas. Genome Medicine. 14(1). 98–98. 30 indexed citations
2.
Pisacane, Alberto, Eliano Cascardi, Enrico Berrino, et al.. (2022). Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs). Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 482(3). 463–475. 14 indexed citations
3.
Verginelli, Federica, Alberto Pisacane, Gennaro Gambardella, et al.. (2021). Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition. Nature Communications. 12(1). 2498–2498. 20 indexed citations
4.
Bacco, Francesca De, Francesca Orzan, Jessica Erriquez, et al.. (2021). ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastoma. Cell Reports. 36(4). 109455–109455. 19 indexed citations
5.
Marchiò, Caterina, Laura Annaratone, Ana Marques, et al.. (2020). Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond. Seminars in Cancer Biology. 72. 123–135. 240 indexed citations
6.
Siravegna, Giulia, Elena Geuna, Benedetta Mussolin, et al.. (2017). Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases. ESMO Open. 2(4). e000253–e000253. 52 indexed citations
7.
Apicella, Maria, Cristina Migliore, Tânia Capelôa, et al.. (2016). Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort. Oncogene. 36(9). 1200–1210. 18 indexed citations
8.
Magro, Gaetano, Alberto Righi, Rosario Caltabiano, Laura Casorzo, & Michal Michal. (2014). Vulvovaginal angiomyofibroblastomas: morphologic, immunohistochemical, and fluorescence in situ hybridization analysis for deletion of 13q14 region. Human Pathology. 45(8). 1647–1655. 20 indexed citations
9.
Casorzo, Laura, Carmine Dell’Aglio, Ivana Sarotto, & Mauro Risio. (2014). Aurora kinase A gene copy number is associated with the malignant transformation of colorectal adenomas but not with the serrated neoplasia progression. Human Pathology. 46(3). 411–418. 22 indexed citations
10.
Magro, Gaetano, Alberto Righi, Laura Casorzo, et al.. (2012). Mammary and vaginal myofibroblastomas are genetically related lesions: fluorescence in situ hybridization analysis shows deletion of 13q14 region. Human Pathology. 43(11). 1887–1893. 79 indexed citations
11.
Cepero, Virna, J. Rafael Sierra, Simona Corso, et al.. (2010). MET and KRAS Gene Amplification Mediates Acquired Resistance to MET Tyrosine Kinase Inhibitors. Cancer Research. 70(19). 7580–7590. 141 indexed citations
12.
Pignochino, Ymera, Ivana Sarotto, Caterina Peraldo‐Neia, et al.. (2010). Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas. BMC Cancer. 10(1). 631–631. 143 indexed citations
13.
Lunghi, Monia, et al.. (2009). Derivative (1)t(1;16)(p11;p11.1) in myelodysplastic syndrome: a case report and review of the literature. Cancer Genetics and Cytogenetics. 196(1). 89–92. 1 indexed citations
14.
Sangiolo, Dario, Emanuela Martinuzzi, Maja Todorovic, et al.. (2008). Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers. International Immunology. 20(7). 841–848. 98 indexed citations
15.
Casorzo, Laura, et al.. (2005). Fluorescence in situ hybridization (FISH) evaluation of chromosomes 6, 7, 9 and 10 throughout human melanocytic tumorigenesis. Melanoma Research. 15(3). 155–160. 32 indexed citations
16.
Cignetti, Alessandro, Antonella Vallario, Ilaria Roato, et al.. (2004). Leukemia-Derived Immature Dendritic Cells Differentiate into Functionally Competent Mature Dendritic Cells That Efficiently Stimulate T Cell Responses. The Journal of Immunology. 173(4). 2855–2865. 47 indexed citations
17.
Montemurro, Filippo, Ivana Sarotto, Laura Casorzo, et al.. (2004). HER2 and Central Nervous System Metastasis in Patients with Breast Cancer. Clinical Breast Cancer. 5(3). 232–234. 3 indexed citations
18.
Risio, Mauro, Gaetano De Rosa, Ivana Sarotto, et al.. (2003). HER2 testing in gastric cancer: Molecular morphology and storage time-related changes in archival samples. International Journal of Oncology. 23(5). 1381–7. 24 indexed citations
19.
Casorzo, Laura, Laura Chiecchio, Alberto Pisacane, et al.. (2003). Cytogenetic findings in a case of dedifferentiated chondrosarcoma. Cancer Genetics and Cytogenetics. 144(1). 61–64. 10 indexed citations
20.
Casorzo, Laura, et al.. (1998). Gastrointestinal Stromal Tumor, Uncommitted Type, with Monosomies 14 and 22 as the Only Chromosomal Abnormalities. Cancer Genetics and Cytogenetics. 102(2). 135–138. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcel Bundi Breakdown of academic impact, for papers by Philipp Lohneis Breakdown of academic impact, for papers by Xiaopei Zhu Breakdown of academic impact, for papers by Leonardo Faoro Breakdown of academic impact, for papers by Herman Bril Breakdown of academic impact, for papers by Raija Ristamäki Breakdown of academic impact, for papers by Koh‐ichi Sakata Breakdown of academic impact, for papers by Naoki Kanomata Breakdown of academic impact, for papers by Martin Illemann Breakdown of academic impact, for papers by Priyanka Shivdasani
Rankless by CCL
2026